MACSF

COMMUNIQUÉS West-GlobeNewswire

Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide
15/07/2025
Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension This patent covers novel cyclic peptides and their use in treating solid tumors BASKING RIDGE, N. [...]
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
15/07/2025
TARPON SPRINGS, Fla., July 15, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual [...]
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
15/07/2025
Company Advances its Progress toward FDA Premarket Approval Study for its Next Generation Colorectal Cancer Screening Product and Makes a Strategic Acquisition in the Field of Pancreatic Cancer Screening BERKELEY, Calif [...]
Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled
15/07/2025
Vancouver, Canada, July 15, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan
15/07/2025
Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in [...]
MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy
15/07/2025
iNKT cells uniquely remodel the tumor microenvironment, overcome immune resistance, and enable scalable off-the-shelf cell therapy NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a [...]
Sienna Announces July Dividend
15/07/2025
MARKHAM, Ontario, July 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
15/07/2025
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System
15/07/2025
Continuing strong procedure growth, including an upsurge in telesurgeries FORT LAUDERDALE, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII) , [...]
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices
15/07/2025
VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is [...]
Beverly Hills MD Launches Metabolic Reset: A Revolutionary Weight Management Support Formula
15/07/2025
Beverly Hills MD Metabolic Reset: A Supplement Designed to Activate Your Body’s Natural Weight Management Mechanisms BEVERLY HILLS, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Beverly Hills MD ® , founded by renowned [...]
Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation
15/07/2025
CANTON, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Myriad Genetics Earns 2025 Great Place To Work Certification™
15/07/2025
SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has received the Great Place to Work [...]
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
15/07/2025
$10 million securities purchase agreement provides efficient and flexible funding in support of strategic multi-million dollar growth initiatives Discussions underway to expand adoption of ChemoFx in the U.S. and [...]
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
15/07/2025
SAN JOSE, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]
Evestia Clinical to merge with Atlantic Research Group
15/07/2025
Kester Capital-backed Evestia Clinical merges with US-based Atlantic Research Group (ARG) to create a leading independent global specialist CRO in fast-growing markets The merger delivers on Evestia Clinical’s strategy [...]
Award-Winning Holixer from Natural Remedies Delivers Clinically Proven Sleep Support
15/07/2025
BANGALORE, India, July 15, 2025 (GLOBE NEWSWIRE) -- With rising nighttime temperatures disrupting sleep across the United States, clinical research shows Holixer™, a patented and clinically validated extract from [...]
Circuit Clinical Partners with Western New York Medical to Expand Access to Clinical Trials in Buffalo
15/07/2025
BUFFALO, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Circuit Clinical , is proud to announce a new partnership with Western New York Medical (WNY Medical) to bring clinical trials directly to patients in central Buffalo. [...]
60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
15/07/2025
$5 million upfront with up to an additional $5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants WASHINGTON, July 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc [...]

Pages